![JCM | Free Full-Text | Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies JCM | Free Full-Text | Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies](https://pub.mdpi-res.com/jcm/jcm-11-06254/article_deploy/html/images/jcm-11-06254-g001.png?1667892707)
JCM | Free Full-Text | Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies
![PDF] Metronomic chemotherapy from rationale to clinical studies: a dream or reality? | Semantic Scholar PDF] Metronomic chemotherapy from rationale to clinical studies: a dream or reality? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e3d28e4827e99a9dbc87dcdb1d329e8725145241/3-Figure1-1.png)
PDF] Metronomic chemotherapy from rationale to clinical studies: a dream or reality? | Semantic Scholar
![Mechanisms of action of metronomic chemotherapy. The beneficial effects... | Download Scientific Diagram Mechanisms of action of metronomic chemotherapy. The beneficial effects... | Download Scientific Diagram](https://www.researchgate.net/publication/258036992/figure/fig1/AS:297351680937988@1447905573248/Mechanisms-of-action-of-metronomic-chemotherapy-The-beneficial-effects-of-metronomic.png)
Mechanisms of action of metronomic chemotherapy. The beneficial effects... | Download Scientific Diagram
![Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis - Arrivi - 2022 - Journal of Neuroendocrinology - Wiley Online Library Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis - Arrivi - 2022 - Journal of Neuroendocrinology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/be543cd0-285d-40f5-b64b-68faad26ba2c/jne13189-toc-0001-m.jpg?trick=1681087570996)
Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis - Arrivi - 2022 - Journal of Neuroendocrinology - Wiley Online Library
![Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development | Future Oncology Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.15.306/asset/images/medium/figure2.gif)
Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development | Future Oncology
![The use of low‐dose metronomic chemotherapy in dogs—insight into a modern cancer field - Gaspar - 2018 - Veterinary and Comparative Oncology - Wiley Online Library The use of low‐dose metronomic chemotherapy in dogs—insight into a modern cancer field - Gaspar - 2018 - Veterinary and Comparative Oncology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/31d077f9-d97d-4689-bf8b-2812c7d60d1e/vco12309-fig-0001-m.jpg)
The use of low‐dose metronomic chemotherapy in dogs—insight into a modern cancer field - Gaspar - 2018 - Veterinary and Comparative Oncology - Wiley Online Library
![Cancers | Free Full-Text | Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment Cancers | Free Full-Text | Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment](https://www.mdpi.com/cancers/cancers-13-05414/article_deploy/html/images/cancers-13-05414-g001.png)
Cancers | Free Full-Text | Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
![Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health](https://www.thelancet.com/cms/attachment/e977474a-6e1f-4500-b5df-bcde846c02df/gr1.gif)